There are 805 resources available
133O - Safety of 30 min infusion of durvalumab (D) in combination with gemcitabine (G)-based chemotherapy in first-line treatment (tx) of advanced biliary tract cancer (aBTC): TOURMALINE early results
Presenter: Masafumi Ikeda
Session: Proffered Paper session: Gastrointestinal tumours
Resources:
Abstract
134O - Asia subgroup overall survival and long-term follow-up results of the phase IIb HERIZON-BTC-01 study: Zanidatamab in previously treated human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC)
Presenter: Jin Won Kim
Session: Proffered Paper session: Gastrointestinal tumours
Resources:
Abstract
60O - A phase Ia study of DNP002, a monoclonal antibody that binds to tumor-associated CEACAM family proteins, in patients with advanced solid tumors: Interim results from dose escalation study
Presenter: Wonyoung Choi
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
YO34 - A recalcitrant case of chronic diarrhea in a young female and a near miss in diagnosis – a case report
Presenter: Abdul Raheem
Session: Young Oncologists clinical cases discussion
Resources:
Abstract
61O - Updated results of a phase II trial evaluating an anti-EpCAM x anti-CD3 bispecific antibody, M701, for the treatment of malignant ascites
Presenter: Rongrui Liu
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
YO33 - Muco-cutaneous adverse drug reaction associated with oral Temozolomide in a case of GBM : when rare become common.
Presenter: Abdul Mannan
Session: Young Oncologists clinical cases discussion
Resources:
Abstract
479MO - Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)
Presenter: Ji Won Lee
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
480MO - Prevalence and characteristics of TP53 Y220C mutations in patients with solid malignancies
Presenter: Yostena Mekhail
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
YO27 - Negative Predicting Value of Longitudinal Undetectable MRD in Maintenance Immunotherapy for Advanced Lung Cancer Patients: A Case Report
Presenter: Hua Zheng
Session: Young Oncologists clinical cases discussion
Resources:
Abstract
481MO - Next-generation sequencing (NGS) of paired tumor tissue and blood samples from patients with advanced solid cancers: A complementary approach
Presenter: Nitesh Rohatgi
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract